Registry study for Exablate thalamotomy in tremor-dominant Parkinson’s
Part of Brain & nervous system clinical trials.
This study follows people who are getting an Exablate procedure to treat medication-resistant, tremor-dominant Parkinson’s. It aims to track safety and outcomes in real-world care after the treatment is approved.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 30 or older
- Be scheduled to receive an Exablate procedure for your planned thalamotomy treatment
- Be willing and able to follow the study plan, including visits and required check-ins
- Have signed the informed consent form and received a copy
- Plan to participate for the full study duration (not just part of the time)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is a real-world registry that follows people with Parkinson’s who are planning to get an Exablate 4000 procedure (a focused ultrasound treatment) for one-sided symptoms that are difficult to control with medication. It mainly checks outcomes and safety over time, helping doctors understand how well this treatment works in everyday care.
This trial tests a second focused ultrasound treatment for people with essential tremor who have already had one side treated. It checks if treating the other side helps control tremors better.
This trial uses focused ultrasound to treat tremor and movement problems in Parkinson's disease. It targets a specific brain area without surgery, and may help if your symptoms are worse on one side and not fully controlled by medication.
This study tests whether a second focused ultrasound treatment on the other side of the brain can safely and effectively reduce tremor in people with essential tremor who already had one treatment. It's for those whose tremor is not well controlled by medication or previous treatments.
This trial tests a non-surgical treatment that uses focused ultrasound waves to create tiny lesions in a specific part of the brain to improve Parkinson's symptoms like stiffness, slowness, and involuntary movements. It may be an option for people who have had Parkinson's for a while and have motor complications from their medications.
This trial tests an upgraded deep brain stimulation (DBS) system that can “sense” tremor and adjust treatment in a loop. It’s designed for people with severe essential tremor whose tremor is still disabling despite standard DBS and medication.
Hear when a new Tremor Associated With Tremor Dominant Parkinson's Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.